🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Representation of Diet in the Management of Type 2 Diabetes in Migrant Patients at CHSD

Recruitingn/aAges 18 Years - anyAllCentre Hospitalier de Saint-Denis
NCT06969391 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This observational and monocentric study aims to explore how migrant patients with type 2 diabetes perceive and represent food in the context of their diabetes care. Conducted at the Centre Hospitalier de Saint-Denis, the study investigates the cultural, social, and personal factors that influence dietary habits and how these perceptions affect the management of their condition. The goal is to improve the understanding of patient behaviors and support more culturally adapted care strategies.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Type 2 diabetic for at least 3 months * Arrived in France less than 7 years ago * Adult patient (age 18) * Speaking French or English Exclusion Criteria: * Minor patient (age \< 18 years) * Type 1 diabetes * Does not speak French or English * Patient who has expressed opposition to the use of his data, or his refusal to participate
💊

What it tests

  • Not listed
📍

Where

1 site
Centre Hospitalier (CH) de Saint-Denis
Saint-Denis, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy